| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/09/2001 | US6172040 Meat microbiocide |
| 01/09/2001 | US6172039 Expression of recombinant hemoglobin and hemoglobin variants in yeast |
| 01/09/2001 | US6172038 Antipathogenic peptides and compositions comprising them |
| 01/09/2001 | US6171860 Oligonucleotides which target untranslated regions and start codons to prevent transcription of a gene; for treatment of bone disorders, inflammation and cancer; antiinflammatory agents; anticarcinogenic agents; antitumor agents |
| 01/09/2001 | US6171859 Defective cytochrome c oxidase; diagnosing alzheimer*s disease |
| 01/09/2001 | US6171856 Methods and compositions relating to no-mediated cytotoxicity |
| 01/09/2001 | US6171840 LacC from streptococcus pneumoniae |
| 01/09/2001 | US6171838 ratB |
| 01/09/2001 | US6171835 ribH |
| 01/09/2001 | US6171827 Procollagens |
| 01/09/2001 | US6171824 Polypeptide includes four alpha-helical and three linking sequences from leukemia inhibitory factor, granulocyte colony stimulating factor, interleukin-6, interleukin-11, ciliary neurotrophic factor, and oncostatin-m; therapy |
| 01/09/2001 | US6171820 Saturation mutagenesis in directed evolution |
| 01/09/2001 | US6171818 Amino acid sequence of polypeptide from aplysia punctata, a sea snail; for recombinant production of anticarcinogenic agents |
| 01/09/2001 | US6171816 Human XAG-1 polynucleotides and polypeptides |
| 01/09/2001 | US6171815 Human sulfonylurea receptor |
| 01/09/2001 | US6171806 Isolated peptide defined by SEQ ID NO: 17 and uses thereof |
| 01/09/2001 | US6171805 Immunoassay diagnosis of periodontal disease by contacting serum sample with cell surface polypeptide of defined amino acid sequence and detecting antibodies which bind to polypeptide |
| 01/09/2001 | US6171803 Drug screening for allergy treatments by engineering expression of alpha, beta, and gamma subunits of receptor in host cell, incubating with candidate inhibitor, and analyzing for cell expression or cell activation |
| 01/09/2001 | US6171799 Immunoassay detection of a v beta 5.3 t cell by contacting tissue sample with a monoclonal antibody which reacts to variable region of beta chain of the receptor; diagnosis and treatment of rheumatoid arthritis |
| 01/09/2001 | US6171791 From the transmembrane receptor tyrosine kinase; for diagnosis of human cancer, especially of neural crest origin |
| 01/09/2001 | US6171790 Human protease associated proteins |
| 01/09/2001 | US6171787 Detecting polynucleotide of tumor necrosis factor-gamma in sample by contacting with polynucleotide of defined nucleotide sequence and determining binding/hybridization; diagnosis of inflammation and related disorders |
| 01/09/2001 | US6171786 Contacting cell with phosphoinositol-dependent phospholipase c inhibitor along with cytotoxic drug |
| 01/09/2001 | US6171781 NF-AT polypeptides and polynucleotides |
| 01/09/2001 | US6171779 HMGI proteins in cancer |
| 01/09/2001 | US6171620 Method of enhancing the efficacy of anti-tumor agents |
| 01/09/2001 | US6171612 Gene therapy |
| 01/09/2001 | US6171598 GTP cyclohydrolase II (RIBA) |
| 01/09/2001 | US6171592 Equine rhinovirus 1 proteins |
| 01/09/2001 | US6171590 Treatment and prevention of inflammatory responses. |
| 01/09/2001 | US6171588 Anti-αvβ3 integrin antibody antagonists |
| 01/09/2001 | US6171587 Antibodies to tissue factor inhibitor |
| 01/09/2001 | US6171584 Method of treatment with growth/differentiation factors of the TGF-β family |
| 01/09/2001 | US6171578 Glycoprotein iib/iiia receptor-binding benzodiazepine derivatives covalently linked to metal ion chelators. |
| 01/09/2001 | CA2219924C Moist bacteriocin disinfectant wipes and methods of using the same |
| 01/09/2001 | CA2204640C Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 01/09/2001 | CA2192079C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 01/04/2001 | WO2001001627A2 Server-assisted regeneration of a strong secret from a weak secret |
| 01/04/2001 | WO2001001139A2 Incorporation and appliations of biomolecular interactions within a carrier |
| 01/04/2001 | WO2001001130A1 METHODS AND COMPOSITIONS RELATING TO PANCREATIC ISLET AND β-CELL DYSFUNCTION |
| 01/04/2001 | WO2001000881A1 Antisense modulation of pi3k p85 expression |
| 01/04/2001 | WO2001000879A1 Novel kinases and uses thereof |
| 01/04/2001 | WO2001000878A2 A novel vascular endothelial growth factor family member and uses thereof |
| 01/04/2001 | WO2001000877A2 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 01/04/2001 | WO2001000874A2 Cancer associated antigens and uses therefor |
| 01/04/2001 | WO2001000872A1 Antisense modulation of beta catenin expression |
| 01/04/2001 | WO2001000861A1 Antisense modulation of g-alpha-s1 expression |
| 01/04/2001 | WO2001000860A2 Prolactin-inducible mammary specific promoter |
| 01/04/2001 | WO2001000854A2 Chimeric proteins mediating targeted apoptosis |
| 01/04/2001 | WO2001000849A1 Tankyrase2 materials and methods |
| 01/04/2001 | WO2001000848A1 Useful polypeptide |
| 01/04/2001 | WO2001000839A1 Tetanus toxin polypeptides |
| 01/04/2001 | WO2001000832A1 Methods for making apo-2 ligand using divalent metal ions |
| 01/04/2001 | WO2001000830A1 Sgip peptides |
| 01/04/2001 | WO2001000829A2 Human endogenous retrovirus in breast cancer |
| 01/04/2001 | WO2001000828A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/04/2001 | WO2001000825A2 Human chromosome 15 and 16 bardet-biedl syndrome polynucleotides and polypeptides and methods of use |
| 01/04/2001 | WO2001000824A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 01/04/2001 | WO2001000823A1 NOVEL ISOFORMS OF THE HUMAN ESTROGEN RECEPTOR-$g(a) |
| 01/04/2001 | WO2001000822A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 01/04/2001 | WO2001000821A1 Antisense oligonucleotide modulating cyclin e gene expression and therapeutic uses thereof |
| 01/04/2001 | WO2001000814A2 Hetero-associating coiled-coil peptides and screenign method therefor |
| 01/04/2001 | WO2001000812A2 22012, a novel human carboxypeptidase |
| 01/04/2001 | WO2001000811A2 17867, a novel human aminopeptidase |
| 01/04/2001 | WO2001000810A1 Glycoprotein vi and uses thereof |
| 01/04/2001 | WO2001000808A1 Antisense modulation of ship-2 expression |
| 01/04/2001 | WO2001000806A2 Dna's encoding proteins with signal peptides |
| 01/04/2001 | WO2001000803A2 Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof |
| 01/04/2001 | WO2001000799A1 Novel protein and dna thereof |
| 01/04/2001 | WO2001000798A2 Cloning and expressing of human cathepsin k in mammalian cells |
| 01/04/2001 | WO2001000792A1 Compositions and methods for forming and strengthening bone |
| 01/04/2001 | WO2001000790A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 01/04/2001 | WO2001000787A2 Methods of treatment using lig 72a and variants thereof |
| 01/04/2001 | WO2001000784A2 Compound derived from an offset orf of the ice gene |
| 01/04/2001 | WO2001000709A1 Copolymers for the transfer of nucleic acids to the cell |
| 01/04/2001 | WO2001000679A2 Methods for inducing t cell non-responsiveness to a tissue or organ graft |
| 01/04/2001 | WO2001000676A1 Somatostatin agonists |
| 01/04/2001 | WO2001000675A1 Protamine-free insoluble acylated insulin compositions |
| 01/04/2001 | WO2001000674A1 Insulin crystals for pulmonary administration |
| 01/04/2001 | WO2001000671A1 Derivative compounds |
| 01/04/2001 | WO2001000670A1 Bh3 modified peptides |
| 01/04/2001 | WO2001000667A2 Anti-thrombin peptide from anopheles albimanus salivary gland |
| 01/04/2001 | WO2001000666A2 Self-aligning peptides derived from human elastin and other fibrous proteins |
| 01/04/2001 | WO2001000665A2 Inhibitors of memapsin 2 and use thereof |
| 01/04/2001 | WO2001000664A2 Secreted alpha-helical protein-36 |
| 01/04/2001 | WO2001000663A2 Catalytically active recombinant memapsin and methods of use thereof |
| 01/04/2001 | WO2001000662A2 The use of human fgh-8 polypeptides as neurotrophic agents |
| 01/04/2001 | WO2001000661A2 Carnitine carrier related protein-1 |
| 01/04/2001 | WO2001000660A1 INHIBITORS OF THE INTEGRIN αvβ¿6? |
| 01/04/2001 | WO2001000659A1 Benzimidazolone peptidomimetics as thrombin receptor antagonists |
| 01/04/2001 | WO2001000658A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/04/2001 | WO2001000657A2 Novel indole peptidomimetics as thrombin receptor antagonists |
| 01/04/2001 | WO2001000656A2 Novel indazole peptidomimetics as thrombin receptor antagonists |
| 01/04/2001 | WO2001000655A2 Therapeutic peptides derived from subsequences of bpi |
| 01/04/2001 | WO2001000654A2 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 01/04/2001 | WO2001000651A1 ANTISENSE MODULATION OF G-ALPHA-i3 EXPRESSION |
| 01/04/2001 | WO2001000649A1 FtsA |
| 01/04/2001 | WO2001000647A1 Antisense modulation of ets-2 expression |
| 01/04/2001 | WO2001000646A1 Antisense modulation of jun n-terminal kinase kinase-2 expression |
| 01/04/2001 | WO2001000645A1 Antisense modulation of integrin beta 3 expression |